Kimball, Alexa B. http://orcid.org/0000-0001-9405-0479
Kirby, Joslyn
Ingram, John R.
Tran, Tanja
Pansar, Ingrid
Ciaravino, Valerie
Willems, Damon
Lewis-Mikhael, Anne-Mary
Tongbram, Vanita
Garg, Amit http://orcid.org/0000-0003-0886-6856
Funding for this research was provided by:
UCB Pharma
Article History
Received: 22 September 2023
Accepted: 8 December 2023
First Online: 6 January 2024
Declarations
:
: Alexa B. Kimball’s institution received grants from Abbvie, Admirx, Anapyts Bio, Aristea, Bristol Myers Squibb, Eli Lilly, Incyte, Janssen, Moonlake, Novartis, Pfizer, Prometheus, UCB; Sonoma Bio; Chemocentryx; she received consulting fees from Abbvie, Alumis, Bayer, Boehringer Ingelheim, Eli Lilly, FIDE, Janssen, Moonlake, Novartis, Pfizer, Priovant, Sonoma Bio, Sanofi, UCB; Target RWE, Ventyx; and serves on the board of directors of Almirall. Joslyn Kirby: Receives a stipend as Editor-in-Chief of the<i> British Journal of Dermatology</i> and an authorship honorarium from UpToDate; consultant for Boehringer Ingelheim, ChemoCentryx, Novartis, and UCB Pharma and has served on advisory boards for Insmed, Kymera Therapeutics, and Viela Bio, all in the field of hidradenitis suppurativa (HS); co-copyright holder of HiSQoL, Investigator Global Assessment and Patient Global Assessment instruments for HS; his department receives income from copyright of the Dermatology Life Quality Instrument (DLQI) and related instruments. John R. Ingram: receives a stipend as Editor-in-Chief of the<i> British Journal of Dermatology</i> and an authorship honorarium from UpToDate. He is a consultant for Abbvie, Boehringer Ingelheim, ChemoCentryx, Citryll, Novartis, UCB Pharma, and UNION Therapeutics and has served on advisory boards for Insmed, Kymera Therapeutics, and Viela Bio. He is co-copyright holder of HiSQOL, Investigator Global Assessment and Patient Global Assessment instruments for HS. His department receives income from copyright of the Dermatology Life Quality Instrument (DLQI) and related instruments. Tanja Tran: Employee of UCB Pharma. Ingrid Pansar, Valerie Ciaravino, Damon Willems: Employees and shareholders of UCB Pharma. Anne-Mary Lewis-Mikhael, Vanita Tongbram: Employees at Icon plc. Amit Garg: Advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, InflaRx, Insmed, Janssen, Novartis, Pfizer, UCB Pharma, Union Therapeutics, and Viela Biosciences, and receives honoraria; research grants from AbbVie, UCB Pharma, and National Psoriasis Foundation; co-copyright holder of the HS IGA and HiSQoL instruments.
: Ethics approval was not required for this study, as this article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.